Projects funded by the NCN

Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

107 projects found matching your search criteria :

  1. Investigation of bacteriophage adhesins with novel fiber-optic sensor as indicators of environmental bacterial contamina...

    Call: SONATA 2 , Panel: NZ7

    Principal investigator: dr Ewa Brzozowska

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  2. Specific Targeting of Antimicrobial Resistant Strains in situ using Targeted-Antibacterial-Plasmids

    Call: JPIAMR-ACTION Call 2021 , Panel: NZ7

    Principal investigator: dr Anna Marzec-Grządziel

    Instytut Uprawy Nawożenia i Gleboznawstwa - Państwowy Instytut Badawczy

  3. Novel hope for diseased joints: a polymer-based treatment to promoteregenerative strategies for patients with osteoarthr...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Marta Kędziora

    Instytut Farmakologii PAN

  4. Novel combination therapies of pulmonary arterial hypertension targeting blockade of peripheral cannabinoid CB1 receptor...

    Call: OPUS 21 , Panel: NZ7

    Principal investigator: prof. Barbara Malinowska

    Uniwersytet Medyczny w Białymstoku

  5. Anticancer activity of novel derivatives of 9,10-Anthraquinone Dithiocarbamates

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Natalia Anna Maciejewska

    Politechnika Gdańska

  6. PDMS-based specially designed microfluidic channel lined with primary endothelial cells: a novel tool for experimental p...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Stefano Rocchetti

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

  7. The search for the novel mechanisms linking intracellular calcium flux regulation with insulin sensitivity response to r...

    Call: OPUS 21 , Panel: NZ7

    Principal investigator: prof. Marek Strączkowski

    Instytut Rozrodu Zwierząt i Badań Żywności PAN

  8. Novel BODIPY derivatives and ruthenium complexes conjugates as photosensitizers for bacterial inactivation in the in viv...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Weronika Porolnik

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  9. Blocking the TNF-TNFR2 interactions as a novel approach to the ovarian carcinoma treatment

    Call: OPUS 21 , Panel: NZ7

    Principal investigator: prof. Sylwia Anna Rodziewicz-Motowidło

    Uniwersytet Gdański, Wydział Chemii

  10. Pharmacological evaluation of possible neuroprotective strategies in novel genetic mouse models of progressive neurodege...

    Call: OPUS 2 , Panel: NZ7

    Principal investigator: dr Grzegorz Kreiner

    Instytut Farmakologii PAN

  11. Selective inhibitors of γ-aminobutyric acid (GABA) transporter subtype 3 (GAT3) as a new pharmacological tools and a cha...

    Call: OPUS 21 , Panel: NZ7

    Principal investigator: dr Dawid Marcin Panek

    Uniwersytet Jagielloński, Collegium Medicum

  12. Selective activation of non-nuclear Estrogen Receptor signaling with PaPE-1 as a novel therapeutic approach for sporadic...

    Call: OPUS 20 , Panel: NZ7

    Principal investigator: prof. Małgorzata Kajta

    Instytut Farmakologii PAN

  13. Enzymes of the L-methionine biosynthetic pathway as novel moleculartargets for antifungal chemotherapy

    Call: OPUS 20 , Panel: NZ7

    Principal investigator: dr hab. Iwona Aniela Gabriel

    Politechnika Gdańska, Wydział Chemiczny

  14. Novel dual CYP17A1 and AKR1C3 inhibitors for studying the mechanism of resistance in prostate cancer

    Call: SONATA 16 , Panel: NZ7

    Principal investigator: dr Tomasz Marcin Wróbel

    Uniwersytet Medyczny w Lublinie

  15. A novel approach based on the optimized multidrug combination for glioblastoma treatment.

    Call: SONATA 16 , Panel: NZ7

    Principal investigator: prof. Małgorzata Kucińska

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  16. Molecular profiling of novel antipsychotic drug candidates

    Call: OPUS 20 , Panel: NZ7

    Principal investigator: dr hab. Jan Manuel Rodriguez Parkitna

    Instytut Farmakologii PAN

  17. Electroporation-based manipulation of drug resistance in cancer using novel nanosecondasymmetrical pulse sequences

    Call: DAINA 2 , Panel: NZ7

    Principal investigator: dr hab. Julita Kulbacka

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej, Wydział Farmaceutyczny

  18. Novel mechanisms of immunomodulation by flame retardants

    Call: OPUS 19 , Panel: NZ7

    Principal investigator: dr hab. Łukasz Pułaski

    Instytut Biologii Medycznej PAN

  19. DNA polymerase θ as a novel therapeutic target in personalized anticancer therapy

    Call: OPUS 19 , Panel: NZ7

    Principal investigator: prof. Tomasz Adam Śliwiński

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

  20. Novel approach in the search for asthma and COPD therapies - computer aided design of multi-target-directed ligands bloc...

    Call: PRELUDIUM 19 , Panel: NZ7

    Principal investigator: Alicja Aleksandra Gawalska

    Uniwersytet Jagielloński, Collegium Medicum

  21. Foldback triplex-forming oligonucleotides as novel tools for G-quadruplex unfolding and selective inhibition of c-Myc on...

    Call: OPUS 19 , Panel: NZ7

    Principal investigator: prof. Anna Pasternak

    Instytut Chemii Bioorganicznej PAN

  22. Combined administration of muscarinic receptor antagonists and group II/III metabotropic glutamate (mGlu) receptor ligan...

    Call: OPUS 19 , Panel: NZ7

    Principal investigator: prof. Andrzej Mikołaj Pilc

    Instytut Farmakologii PAN

  23. Dual histamine H3 and sigma-1 receptor ligands as novel pharmacological tools in the treatment of central nervous system...

    Call: SONATINA 4 , Panel: NZ7

    Principal investigator: Katarzyna Anna Szczepańska

    Instytut Farmakologii PAN

  24. Investigation of novel functionally selective opioid receptors agonists

    Call: ETIUDA 8 , Panel: NZ7

    Principal investigator: Łucja Elżbieta Szumiec

    Instytut Farmakologii PAN

  25. Novel bispecific G-quadruplex conjugates as potential anticancer agents

    Call: PRELUDIUM 18 , Panel: NZ7

    Principal investigator: dr Carolina Sofia Pereira Roxo

    Instytut Chemii Bioorganicznej PAN

  26. Lipophilic Prodrug Charge Masking (LPCM) as a novel strategy to enhance oral bioavailability of charged active peptides....

    Call: SONATA 15 , Panel: NZ7

    Principal investigator: dr Agata Elżbieta Gitlin-Domagalska

    Uniwersytet Gdański, Wydział Chemii

  27. Anticancer activity mechanism and biotechnological obtaining of rinderol - a novel naphthoquinone derivative

    Call: PRELUDIUM 17 , Panel: NZ7

    Principal investigator: Mateusz Krzysztof Kawka

    Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny

  28. Effects of a novel nonaddictive opioid on response to stress

    Call: PRELUDIUM 17 , Panel: NZ7

    Principal investigator: dr Łucja Elżbieta Szumiec

    Instytut Farmakologii PAN

  29. Novel core-shell micro-sized systems for macrophage-targeted drug delivery via phagocytosis

    Call: PRELUDIUM 17 , Panel: NZ7

    Principal investigator: dr Tomasz Marek Urbaniak

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

  30. Novel, rationally designed modulators of glycosomal import of enzymes in Trypanosoma parasites

    Call: OPUS 16 , Panel: NZ7

    Principal investigator: prof. Maciej Filip Dawidowski

    Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny

  31. Prognostic value of platelet-derived microRNAs in patients with acute coronary syndrome treated with novel P2Y12 recepto...

    Call: PRELUDIUM 16 , Panel: NZ7

    Principal investigator: dr hab. Aleksandra Gąsecka-van der Pol

    Warszawski Uniwersytet Medyczny, I Wydział Lekarski

  32. Novel pharmacological strategies for the treatment of depression

    Call: OPUS 16 , Panel: NZ7

    Principal investigator: dr hab. Katarzyna Młyniec

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

  33. Novel hybrid 5-HT6 serotonin receptor and SERT transporter ligands as a therapeutic perspective of behavioural and cogni...

    Call: SONATA 14 , Panel: NZ7

    Principal investigator: dr Agata Siwek

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

  34. Evaluation of therapeutic role of novel positive allosteric modulators of GABA-A receptor in ischemic brain stroke

    Call: SONATA BIS 8 , Panel: NZ7

    Principal investigator: dr Monika Emilia Marcinkowska

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum

  35. Dissecting of the novel mechanisms in multi-drug resistance associated with vault's proteins and translation initiation ...

    Call: SONATA BIS 8 , Panel: NZ7

    Principal investigator: dr hab. Witold Szaflarski

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Lekarski II

  36. Towards novel mechanisms of endothelial dysfunction in E3L.CETP mice displaying hyperlipidaemia with human-like lipoprot...

    Call: OPUS 15 , Panel: NZ7

    Principal investigator: prof. Stefan Karol Chłopicki

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

  37. Novel alkyne derivatives of Safirinium probes: fluorescent labelling of azidothymidine in click chemistry conception

    Call: PRELUDIUM 15 , Panel: NZ7

    Principal investigator: dr Patryk Daniel Kasza

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

  38. Novel human topoisomerase II inhibitors as anticancer agents

    Call: PRELUDIUM 15 , Panel: NZ7

    Principal investigator: dr Barbara Kaproń

    Uniwersytet Medyczny w Lublinie, Wydział Nauk o Zdrowiu

  39. Novel multi-target ligands of aminergic GPCRs as pharmacological tools to study the pathomechanism of schzophrenia

    Call: OPUS 14 , Panel: NZ7

    Principal investigator: dr hab. Agnieszka Anna Kaczor

    Uniwersytet Medyczny w Lublinie, Wydział Farmaceutyczny

  40. Studies on prevalence, circulation and the genetic diversity of novel Porcine Circovirus type 3 (PCV3) in polish swine h...

    Call: PRELUDIUM 13 , Panel: NZ7

    Principal investigator: dr Aleksandra Woźniak

    Szkoła Główna Gospodarstwa Wiejskiego w Warszawie

  41. Novel 2,4-disubstituted pyridine derivatives - synthesis, antimycobacterial activity in vitro, pharmacophore model, mole...

    Call: OPUS 13 , Panel: NZ7

    Principal investigator: dr hab. Katarzyna Małgorzata Gobis

    Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

  42. Novel ligands of histamine receptor H4 as potential anti-allergic and anti-inflammatory drugs

    Call: OPUS 13 , Panel: NZ7

    Principal investigator: prof. Sławomir Hubert Filipek

    Uniwersytet Warszawski, Wydział Chemii

  43. Novel hybrid compounds derived from pyrrolidine-2,5-dione or imidazolidine-2,4-dione scaffold and their effect on centra...

    Call: OPUS 13 , Panel: NZ7

    Principal investigator: dr hab. Krzysztof Tomasz Kamiński

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

  44. CBR1-dependent metabolism and ABCB1-dependent effux of doxorubicin - search for a novel mechanism of reversing resistanc...

    Call: PRELUDIUM 13 , Panel: NZ7

    Principal investigator: Kamil Tomasz Piska

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

  45. Insights into biological activity and mechanism of action of novel styrylquinazoline derivatives as tyrosine kinase inhi...

    Call: PRELUDIUM 12 , Panel: NZ7

    Principal investigator: Katarzyna Anna Malarz

    UNIWERSYTET ŚLĄSKI, Wydział Matematyki, Fizyki i Chemii

  46. Modeling of quantitative structure-metabolic stability relationships as a tool to improve design of potential novel anti...

    Call: OPUS 12 , Panel: NZ7

    Principal investigator: prof. Tomasz Bączek

    Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

  47. The research on the use of novel analogues of endogenous antimicrobial peptides in therapy of staphylococcal skin infect...

    Call: OPUS 12 , Panel: NZ7

    Principal investigator: prof. Wojciech Kamysz

    Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

  48. Functional selectivity of novel histamine H4 receptor ligands

    Call: PRELUDIUM 12 , Panel: NZ7

    Principal investigator: Agnieszka Urszula Olejarz-Maciej

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

  49. Novel glycofullerenes for anti-cancer therapies

    Call: SONATA 12 , Panel: NZ7

    Principal investigator: dr Maciej Michał Serda

    UNIWERSYTET ŚLĄSKI, Wydział Nauk Ścisłych i Technicznych

  50. Novel multi-target directed ligands combining cholinesterase inhibition and 5-HT6 antagonism - design, synthesis and pha...

    Call: SONATA 12 , Panel: NZ7

    Principal investigator: dr hab. Anna Karolina Więckowska

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

O Narodowym Centrum Nauki

Finansowanie nauki

Współpraca zagraniczna

Centrum prasowe

Deklaracja dostępności
Przetwarzanie danych osobowych
Polityka cookies

Partnerzy